chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a fever spike of 104 followed by a down tick in temperature to 90 and also severe chest pains that cause difficulty breathing. I also experienced these symptoms after my second dose.
pt recv vax;exp cellulitis,fever,edema,pressure&swelling of leg,pubic area&penis,chills&malaise;tx w/ pcn for cellulitis;
Acute onset of fever, headache 3 wks post vaccination- Hospitalized 9.8.08. Rx with IV antibiotics. antivirals + IV steroids. Diagnosis- acute disseminated encephalomyelitis.   11/21/08 Reviewed hospital medical records of 9/11-9/18/2008. FINAL DX:acute disseminated encephalomyelitis; right side hemiparesis; elevated blood sugars secondary to steroids. Records reveal patient experienced fever, chills, HA, blurred vision & altered sensorium starting 9/7/08.  Seen in ER where LP revealed abnormal CSF & CT/MRI scan of brain abnormal.  Tx w/IV antibiotics/antivirals & steroids.  Admitted 9/7/08 to ICU but continued to worsen, developed right side weakness & was transferred to higher level of care on 9/11/08.  Repeat LP & MRI abnormal.  D/C antibiotics/antivirals & changed steroids.  ID & rehab consults done.  Patient improved significantly but had right sided weakness, dysmetria, double vision resolved, blood sugars elevated due to steroids.  Transferred to inpatient rehab.  Seen in clinic 11/13/2008 where complete recovery noted & recommended not to receive flu shot.  12/12/2008 Reviewed hospital recorces of 9/8-9/11/2008. FINAL DX: ADEM Records reveal patient experienced severe HA, chills, sweats, fever x 1 day.  Seen in PCP office & sent to ER.  Became unresponsive & transferred to ICU.  Tx w/antivirals, antibiotics, steroids.  Consults done by ID, Neuro & Cardiology.  Improved w/steroids & transferred to higher level of care.
(L) upper arm with 14 1/2 cm length x 11 1/2 cm width rectangular with erythema/& edema slight bruise at injection site (L) arm.
This spontaneous report was received from a medical assistant, referring to a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with and incorrect stored dose of ROTATEQ lot # M043669 with expiration date on 15-JUN-2018 (strength and route were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 47 Fahrenheit grades range for a time frame of 1 hour and 15 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.
mom reports devel fever of 105 on 21AUG93, lethargic & fussy in afternoon; seen @ ER 530 diarrhea started 10PM 21AUG;
Pt stated his Right Deltoid became swollen, red, warm to touch by next day 6/20/18. Presented to office on 6/22/18 to have arm checked. No fever, child, increased pulse, or increased blood pressure. Just localized swelling, warmth, soreness, and redness at area of injection. Both injections within 2 inches on R. Deltoid.
I had routine blood work for my OBGYN and during that blood work my inflammation markers were slightly elevated. I was told to make dietary changes and will get a 2nd blood work next month.
tingling feeling down her legs; joint pain in her legs; raised bumps/rash that appeared chicken pox-like on her face, neck, arms, thighs, legs, and shoulders / rash on chest / rash on back; This case was reported by a consumer and described the occurrence of tingling of extremity in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 6 weeks after receiving Shingrix, the patient experienced tingling of extremity, joint pain and papular rash. The patient was treated with gabapentin. On an unknown date, the outcome of the tingling of extremity, joint pain and papular rash were not recovered/not resolved.   It was unknown if the reporter considered the tingling of extremity, joint pain and papular rash to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not reported. The patient experienced rash that appeared chicken pox-like on her face, neck, arms, thighs, legs and shoulders.  The patient was seen by several dermatologists and the raised bumps were biopsied and proved negative. The patient also reports that she experienced joint pain in her legs, and tingling feeling down her legs. The patient was given Gabapentin to help alleviate symptoms which were still present at the time of reporting. The reporter did not consent to follow-up.
Patient developed large red whelp at injection site with hard knot. Whelp grew in size over 3 days. 08/29/14 called MD and had patient go to office. Dr. said allergic to medicine and had developed infection. Given KEFLEX and prednisone to treat. Patient should recover.
Started with whole body cramps after the first couple days of receiving second dose. Towards the end of week it move to the legs more so on the right side.
DTaP/IPV given L deltoid 8/5/02 developed soreness, redness, swelling. Returned 9/6/02 to clinic with 4" x 4" erythema, induration, pain, edema at L deltoid measures 1+inches> right.
I am feeling like I got hit by a truck; I just feel really tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 27Nov2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset Nov2021, outcome "unknown", described as "I am feeling like I got hit by a truck"; FATIGUE (non-serious) with onset Nov2021, outcome "unknown", described as "I just feel really tired".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
FLULAVAL given to pt in left deltoid, pt presented w/circular rash around site.
10/31/13 presented at urgent care with nausea vomiting since had flu shot at PCP office on 10/29/13. Also arm pain, swelling and redness since injection.
classic symptoms in my right eye - pain, significant/redness/inflammation; some loss of visual acuity; uveitis/prior episodes of iritis/uveitis, but was symptom free; iritis/uveitis/prior episodes of iritis/uveitis, but was symptom free; iritis/prior episodes of iritis/uveitis, but was symptom free; iritis/prior episodes of iritis/uveitis, but was symptom free; classic symptoms in my right eye - pain, significant/redness/inflammation; classic symptoms in my right eye - pain, significant/redness/inflammation; This is a spontaneous report from a contactable consumer (patient). A 49-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9266), via an unspecified route of administration in the left arm on 16Feb2021 15:00 at a single dose for COVID-19 immunisation. The patient's medical history included HLA-B27 gene mutation and iritis/uveitis. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. There were no concomitant medications. On 18Feb2021 23:00, the patient experienced iritis/uveitis. He had prior episodes of iritis/uveitis, but was symptom free and not taking any medications for it as of his innoculation date. He have now developed the classic symptoms in his right eye - pain, significant/redness/inflammation and some loss of visual acuity. Therapeutic measures were taken as a result of prednisone eye drops and ibuprofen (ADVIL) for pain. Outcome of the events was not recovered.
Almost immediately after vaccine, my eyelids started swelling and had a metallic taste in my mouth with heart palpitations. The swelling lasted about 20 minutes and the heart palpitations lasted that lasted for 1 minute.
her arm is a little bit sore; This is a spontaneous report from a Pfizer sponsored program. A Contactable consumer (Patient) reported that a female patient of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Jan2021 at single dose for covid-19 immunization. The patient's medical history was not reported. The patient's concomitant medications were not reported. Concomitant Therapy included physical therapy session today on 26Jan2021. The patient had the vaccine last night (25Jan2021) and had a physical therapy session today, she also mentioned she's not experiencing any adverse event but mentioned that her arm was a little bit sore on an unknown date in Jan2021. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested
booster dose given instead of 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (booster dose given instead of 1st dose) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 18-Nov-2021, the patient experienced INCORRECT DOSE ADMINISTERED (booster dose given instead of 1st dose). On 18-Nov-2021, INCORRECT DOSE ADMINISTERED (booster dose given instead of 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was administered with 0.25ml of booster dose instead of 0.5ml of first dose of Moderna COVID-19 Vaccine. Concomitant medications were not provided. Treatment information was not provided.
Pt received TD 8/12. Started w/ sore throat and fever 8/14. Treated with Rocephin, cot'd w/ fever. Developed myalgias/arthralgias, neck stiffness, headache, rash. Subsequently, admitted 8/17 to hospital. Had (-) spinal tap, (-) CT of head, (-) CXR. urine showed glomerulonephritis. Rash on palms, (-) soles of feet, swollen face and extremities. ? (-). Pt treated with Prednisone 8/18, Benadryl and ??. ?? cont'd with ?? and ??? D/C'd 8/21/02. Nurse follow up on 06/16/04 states: "ADD: Serum Sickness (SERUM SICK) Secondary to Td vax ADD: Pyelonephritis (PYELONEPHRITIS) ADD: (+) ASO Titer (LAB TEST ABNORM)" Nurse follow up on 06/16/04 states: "none."
about 5 days after receiving the vaccines patient experienced fever, tachycardia, rash, body aches, joint aches, muscle aches, headaches , weakness and fatigue. Patient was seen by a provider on 03/22/2021 where a rapid flu and covid tst were ordered to rule out any other illness. At this time due to the muscle aches and weakness provider did order a left LE venous doppler which was negative. All symptoms subsided approximately 3 weeks post vaccine
Patient was fine immediately after his flu shot, has always tolerated them in the past he said and this was his second year getting the high dose according to our records. He went to go do his shopping and came back a few minutes later out of breath and in distress. He said he almost didn't make it back he had sudden severe acute pain in his lower spine with numbness and had a hard time walking/breathing. I checked his BP it was 186/107 with pulse of 57, then 159/91 with a pulse of 48. We used a different machine after he had a while to sit and start feeling better/drink some water and it was 168/96 with pulse 51. I called his doctor's office and let them know what happened.
Large raised rash on her arm, approximately 2 inches wide by 3 inches long around injection site.
Saturday morning- hives on body - got benadryl and 40 mg prednisone  Saturday 10 am tongue swelling and hives on tongue - epi pen  Sunday morning - more hives- benadryl and extra strength pepsid   Hives all over body still (Monday, March 29)
I now have lichen planus. I initially started getting sores on the inside of my mouth, lips, and blisters on my tongue where I was unable to eat. I saw 5 doctors (dermatologist and otolaryngologists). The dentist diagnosed the condition. The condition is still ongoing. No additional care was received.
Fever, headache, body aches, fatigue.  Treated with clear liquids, tylenol and sleep.
It started with ringing in my ears and insomnia. I was told that it could be a inflammatory response causing me to not sleep. My doctor prescribed me Trazodone and Amitriptyline to help me sleep. I have had a month 1/2 of full force anxiety prescribed Lexapro. I was getting heavy and cramps cramps in both legs. It seemed like every week my body  has changed feel depressed. I continue to go to the doctor still exp ringing in my ear asked for a MRI. They found out I have a tumor on right side of my brain scheduled for surgery this week will go to see ENT doctor.
This case was reported by a nurse via sales rep and described the occurrence of shingles in a 54-year-old male patient who received SHINGRIX for prophylaxis. On 6th August 2018, the patient received the 1st dose of SHINGRIX. In August 2018, 7 days after receiving SHINGRIX, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown. It was unknown if the reporter considered the shingles and rash to be related to SHINGRIX. Additional details were provided as follows: About a week after receiving SHINGRIX, the patient experienced rash. The patient visited office on 22nd August 2018 and the doctor confirmed it was mild case of Shingles.
Redness, swelling and pain to left deltoid. On 1/12/01 at 14:30 was seen by MD. Ice to area and Motrin. Rechecked on 1/13/01 and mother states area looks better than yesterday. Improvement after ice application on 1/12/01.
Patient felt her throat swelling. Self injected her own Epipen. Started 5 minutes after receiving immunizations. Patient states she uses Epipen frequently as is allergic to many things. EMS arrived to check patient. Patient did not go to hospital and was released from store by EMS.
Had large local reaction to Pneumovax as well as fevers, rigors, myalgias present on 3/11/2012. Had hep A, influenza, Menactra same day other arm; had Adacel same day same arm.
Varicella, fever, nasal secretion. This pt was IZ with first dose. Pt's sister was also IZ, same date, with first dose of vax developed chickenpox. As a result of the varicella exposure and the nurse practitioner's experience was that children from Honduras develop severe chickenpox, the physician decided to revaccinate the pt in the left arm SC with a second dose of varicella virus vaccine live on 01/25/2000. ON 02/05/2000, the pt had prodromal consisting of a runny nose, fever (100), and a rash. The rash was noted to be a severe case of chickenpox consisting of lesions in his ear which were treated with antibiotics. the reporter felt that the pt's experience was an
Fever, headache (around 3:00pm-8:00pm that evening).  Severe chest pains radiating throughout my upper chest, back shoulders. Same side affect as when I take PCE (Erythromycin). Around 1:00-5:00 am.
Sick; Initial information received on 08-Nov-2021 regarding an unsolicited valid social media non-serious case received from a consumer or non-healthcare professional via Digital Media.  This case involves adult patient (unknown demographic) who had sick (illness) after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was reported " I have only took the flu shot twice in my lifetime, and both times I got sick and people think after that, im going to take the covid, vaccine."  There were no lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
COVID-19; COVID-19; This is a spontaneous report received from a contactable nurse. A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) dose 1, single on 18Mar2021 and dose 2, single on 08Apr2021; both given via unspecified route of administration, at the age of 62-year-old, for covid-19 immunisation. The patient medical history was not reported. The patient had no concomitant medications. The patient is not pregnant at the time of vaccination. The patient did not receive other vaccine in four weeks and was not previously diagnosed with COVID. On 02Oct2021, the patient experienced Covid-19. The event resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test and procedures which included nasal swab which showed positive result on 02Oct2021. Therapeutic measures taken in response to the event included administration of monoclonal antibodies. Outcome of the event was not recovered.   The lot number for [BNT162B2] was not provided and will be requested during follow-up.; Sender's Comments: Based on the information currently available,The casual association between the reported event "Covid-19" and suspected vaccine BNT162B2 cannot be completely excluded.
pt recv vax 10JUL96 & 11JUL96 t99.7 lt arm @ DTAP site shows localized redness;mom reports last PM had extreme chills & fever;saw MD 11JUL96 was told nothing is wrong;
Patient's arm was sore the day of vaccine. The next day (11/4/18) the patient's arm became very red, hot, swollen, painful to the touch and muscle was very sore. Patient is feeling better on 11/5/18  but it is not resolved. Arm is still sore and it is inhibiting him from going climbing with his family.
face was all swollen; eyes were puffy; throat felt swollen; couldn't pee; She could still breath; stomach was swollen; retaining a lot of water after the vaccine.; chronic pain; throat felt thick; strong headache; just really tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face was all swollen), PERIORBITAL SWELLING (eyes were puffy), PHARYNGEAL SWELLING (throat felt swollen), DYSURIA (couldn't pee) and DYSPNOEA (She could still breath) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Flu vaccination (Flu vaccine) and Food allergy (Avocado).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (face was all swollen), PERIORBITAL SWELLING (eyes were puffy), PHARYNGEAL SWELLING (throat felt swollen), DYSURIA (couldn't pee), DYSPNOEA (She could still breath), ABDOMINAL DISTENSION (stomach was swollen), FLUID RETENTION (retaining a lot of water after the vaccine.), PAIN (chronic pain), PHARYNGEAL OEDEMA (throat felt thick), HEADACHE (strong headache) and FATIGUE (just really tired). At the time of the report, SWELLING FACE (face was all swollen), PERIORBITAL SWELLING (eyes were puffy), PHARYNGEAL SWELLING (throat felt swollen), DYSPNOEA (She could still breath), FLUID RETENTION (retaining a lot of water after the vaccine.), PAIN (chronic pain), PHARYNGEAL OEDEMA (throat felt thick), HEADACHE (strong headache) and FATIGUE (just really tired) outcome was unknown, DYSURIA (couldn't pee) had resolved and ABDOMINAL DISTENSION (stomach was swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was given. Laboratory details given as blood glucose decreased on an unknown date. No treatment information was given
Delayed induration and induration at injection site. Started 72 hours after vaccine continuing at least till day 9. Likely DTH/ Type IV reaction
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 07Oct2021 (Lot number: FF2589) at the age of 64 years as dose 3 (booster), single, administration date 19Mar2021 (Lot number: EN6208) as dose 2, single and administration date 26Feb2021 (Lot number: EN6202) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "COPD" (unspecified if ongoing); "Osteoporosis" (unspecified if ongoing); "High BP" (unspecified if ongoing); "High Cholesterol" (unspecified if ongoing). Concomitant medication(s) included: DILTIAZEM HCL, start date: Feb2020, stop date: 12Mar2022; ATORVASTATIN, start date: Sep2021, stop date: 08Mar2022; CENTRUM SILVER +50, start date: Sep2017, stop date: 08Mar2022; VIACTIV [CALCIUM], start date: Jan2019, stop date: 08Mar2022; WIXELA INHUB, start date: Feb2014, stop date: Mar2022; ALBUTEROL [SALBUTAMOL], start date: 01Mar2022, stop date: 12Mar2022. Past drug history included: Prednisone, reaction(s): "known allergies: Prednisone", notes: known allergies: Prednisone. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Product: COVID 19 Treatment: Paxlovid". Therapeutic measures were taken as a result of suspected Covid-19. Clinical comment: The COVID-19 treatment included Paxlovid from 09Mar2022 to Mar2022 (lot number: FW6344). No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
About 10 hours after vaccine, severe headache (lasted 10 hours) (On a scale of 1-10, headache was a 9) About 12 hours after vaccine, severe nausea (lasted 6 hours) (On a scale of 1-10, nausea was a 9) About 12 hours after vaccine, fever (99.5) and chills, lasted about 4 hours About 14 hours after vaccine, body aches (On a scale of 1-10, aches were a 5), lasted about 4 hours About 16 hours after vaccine, unusual thirst (On a scale of 1-10, thirst was an 8), lasted about 2 hours
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM HYPOXIA